Cost-Effectiveness Analyses
نویسندگان
چکیده
منابع مشابه
The Core Value of Cost-Effectiveness Analyses.
O ver the past 4 years, transcatheter aortic valve replacement (TAVR) has transformed the cardiac care of patients in the United States with severe aortic stenosis (SAS). In September 2011, a balloon-expandable prosthesis (Sapien, Edwards Lifesciences, Irvine, California) received U.S. Food and Drug Administration (FDA) approval for the treatment of inoperable patients on the basis of a randomi...
متن کاملAddressing risk preferences in cost-effectiveness analyses.
Cost-effectiveness analysis is a form of economic evaluation that compares that compares the costs and effectiveness of health interventions, where effectiveness is measured in a single scale. Despite the growth in the popularity of cost-effectiveness analysis, very few cost-effectiveness analyses adequately measure and account for uncertainty. In the health economics literature, two schools of...
متن کاملClinical trial-based cost-effectiveness analyses of antipsychotic use.
OBJECTIVE Second-generation antipsychotics make up one of the fastest growing segments of the rapidly growing pharmaceutical sector. Given limited health care resources, assessment of the value for the cost of second-generation antipsychotics relative to first-generation antipsychotics is critical for resource-allocation decisions. METHOD With a MEDLINE search, the authors identified eight st...
متن کاملCost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review
CONTEXT Hypertension affects one third of the U.S. adult population. Although cost-effectiveness analyses of antihypertensive medicines have been published, a comprehensive systematic review across medicine classes is not available. EVIDENCE ACQUISITION PubMed, Embase, Cochrane Library, and Health Technology Assessment were searched to identify original cost-effectiveness analyses published f...
متن کاملPredicting survival in cost-effectiveness analyses based on clinical trials.
This study deals with the question of how to model health effects after the cessation of a randomized controlled trial (RCT). By using clinical trial data on severe congestive heart failure patients, we illustrate how survival beyond the cessation of an RCT can be predicted based on parametric survival models. In the analysis, we compare predicted survival and the resulting incremental cost-eff...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Internal Medicine
سال: 2001
ISSN: 0003-4819
DOI: 10.7326/0003-4819-135-5-200109040-00021